BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 33081348)

  • 41. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
    Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
    Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transition metal chelator therapy--a potential treatment for Alzheimer's disease?
    Gnjec A; Fonte JA; Atwood C; Martins RN
    Front Biosci; 2002 Apr; 7():d1016-23. PubMed ID: 11897554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species.
    Tiiman A; Luo J; Wallin C; Olsson L; Lindgren J; Jarvet J; Per R; Sholts SB; Rahimipour S; Abrahams JP; Karlström AE; Gräslund A; Wärmländer SK
    J Alzheimers Dis; 2016 Oct; 54(3):971-982. PubMed ID: 27567855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Water-Soluble Peptoid Chelator that Can Remove Cu
    Behar AE; Sabater L; Baskin M; Hureau C; Maayan G
    Angew Chem Int Ed Engl; 2021 Nov; 60(46):24588-24597. PubMed ID: 34510664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
    Price KA; Crouch PJ; White AR
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
    Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
    ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amyloid-beta metal interaction and metal chelation.
    Cuajungco MP; Frederickson CJ; Bush AI
    Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.
    Bagheri S; Squitti R; Haertlé T; Siotto M; Saboury AA
    Front Aging Neurosci; 2017; 9():446. PubMed ID: 29472855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
    Mancino AM; Hindo SS; Kochi A; Lim MH
    Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease.
    Drew SC
    Front Neurosci; 2017; 11():317. PubMed ID: 28626387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    Squitti R; Faller P; Hureau C; Granzotto A; White AR; Kepp KP
    J Alzheimers Dis; 2021; 83(1):23-41. PubMed ID: 34219710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. β-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species.
    Mayes J; Tinker-Mill C; Kolosov O; Zhang H; Tabner BJ; Allsop D
    J Biol Chem; 2014 Apr; 289(17):12052-12062. PubMed ID: 24619420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methods for analyzing the coordination and aggregation of metal-amyloid-β.
    Park S; Na C; Han J; Lim MH
    Metallomics; 2023 Jan; 15(1):. PubMed ID: 36617236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Zatta P; Drago D; Bolognin S; Sensi SL
    Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.
    Atwood CS; Obrenovich ME; Liu T; Chan H; Perry G; Smith MA; Martins RN
    Brain Res Brain Res Rev; 2003 Sep; 43(1):1-16. PubMed ID: 14499458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silicon-Carbon Dots-Loaded Mesoporous Silica Nanocomposites (mSiO
    Li QY; Yu X; Li X; Bao LN; Zhang Y; Xie MJ; Jiang M; Wang YQ; Huang K; Xu L
    ACS Appl Mater Interfaces; 2023 Nov; 15(47):54221-54233. PubMed ID: 37962427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.